Evogene EVGN
NASDAQ EVGN
$0.56 +0.00 (+0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evogene (EVGN) Prepaid Assets (2016 - 2018)

Evogene (EVGN) posted Prepaid Assets of $275000.0 for Q4 2018, up 23.32% sequentially from $223000.0 in Q4 2017, and up 23.32% YoY from $223000.0 in Q4 2017.

Evogene (EVGN) Prepaid Assets (2016 - 2018) Analysis & Trends

Evogene has reported Prepaid Assets for 3 years, with the latest figure at $275000.0 in Q4 2018.

  • Quarterly Prepaid Assets rose 23.32% year-over-year to $275000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $275000.0 (up 23.32% YoY) and the FY2018 annual result came in at $275000.0, up 23.32% from the prior year.
  • Prepaid Assets grew to $275000.0 in Q4 2018 per EVGN's latest filing, from $223000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $275000.0 in Q4 2018 and troughed at $157000.0 in Q4 2016.
  • A 3-year average of $218333.3 and a median of $223000.0 in 2017 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2017 and 2018: Prepaid Assets jumped 42.04% in 2017, then advanced 23.32% in 2018.
  • Over 3 years, Prepaid Assets stood at $157000.0 in 2016, then soared by 42.04% to $223000.0 in 2017, then rose by 23.32% to $275000.0 in 2018.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $275000.0, $223000.0, and $157000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Evogene 4.38 Mn 4.38 Mn 204,000.00

Historic Data

Download Data
DateValue
Dec 31, 2018 275,000.00
Dec 31, 2017 223,000.00
Dec 31, 2016 157,000.00